Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · Real-Time Price · USD

Compare

10.55

+0.13 (1.25%)

At close: Oct 24, 2025, 4:00 PM EDT

10.40

-0.15 (-1.42%)

After-hours: Oct 24, 2025, 4:48 PM EDT

Amneal Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	2,853	2,794	2,394	2,212	2,094	1,993	Upgrade
Revenue Growth (YoY)	9.81%	16.73%	8.20%	5.67%	5.08%	22.51%	Upgrade
Cost of Revenue	1,785	1,778	1,530	1,421	1,310	1,340	Upgrade
Gross Profit	1,068	1,016	863.87	791.46	783.95	652.32	Upgrade
Selling, General & Admin	489.93	476.44	429.68	399.7	365.5	326.73	Upgrade
Research & Development	203.37	190.71	163.95	195.69	201.85	179.93	Upgrade
Other Operating Expenses	-5.22	-	-1.14	-3.96	-	-	Upgrade
Operating Expenses	688.08	667.15	592.49	591.43	567.35	506.66	Upgrade
Operating Income	379.82	348.36	271.38	200.03	216.6	145.66	Upgrade
Interest Expense	-249.21	-258.6	-210.63	-158.38	-136.33	-146	Upgrade
Currency Exchange Gain (Loss)	7.12	-6.85	1.67	-12.36	-0.36	16.35	Upgrade
Other Non Operating Income (Expenses)	-44.92	-42.66	5.12	17.83	15.33	2.59	Upgrade
EBT Excluding Unusual Items	92.8	40.26	67.54	47.13	95.25	18.6	Upgrade
Merger & Restructuring Charges	-2.26	-2.36	-1.75	-2.13	-9.91	-11.39	Upgrade
Gain (Loss) on Sale of Assets	-	3.76	-	-	-	0.12	Upgrade
Asset Writedown	-0.92	-0.92	-36.13	-11.11	-22.69	-34.58	Upgrade
Legal Settlements	-1.24	-96.69	-1.82	-269.93	-25	-5.86	Upgrade
Other Unusual Items	0.93	0.93	-37.31	-1.02	-10.57	-	Upgrade
Pretax Income	89.3	-55.01	-40.27	-248.13	31.37	-35.78	Upgrade
Income Tax Expense	38.06	18.86	8.45	6.66	11.2	-104.36	Upgrade
Earnings From Continuing Operations	51.24	-73.88	-48.72	-254.79	20.17	68.58	Upgrade
Minority Interest in Earnings	-47.87	-43.01	-35.27	124.8	-9.55	22.48	Upgrade
Net Income	3.38	-116.89	-83.99	-129.99	10.62	91.06	Upgrade
Net Income to Common	3.38	-116.89	-83.99	-129.99	10.62	91.06	Upgrade
Net Income Growth	-	-	-	-	-88.33%	-	Upgrade
Shares Outstanding (Basic)	311	309	176	151	149	147	Upgrade
Shares Outstanding (Diluted)	316	309	176	151	152	149	Upgrade
Shares Change (YoY)	24.70%	75.42%	16.69%	-0.58%	1.95%	12.72%	Upgrade
EPS (Basic)	0.01	-0.38	-0.48	-0.86	0.07	0.62	Upgrade
EPS (Diluted)	0.01	-0.38	-0.48	-0.86	0.07	0.61	Upgrade
EPS Growth	-	-	-	-	-88.52%	-	Upgrade
Free Cash Flow	270.88	234.76	298.78	16.3	190.88	317.17	Upgrade
Free Cash Flow Per Share	0.86	0.76	1.70	0.11	1.26	2.13	Upgrade
Gross Margin	37.43%	36.35%	36.09%	35.77%	37.44%	32.74%	Upgrade
Operating Margin	13.31%	12.47%	11.34%	9.04%	10.35%	7.31%	Upgrade
Profit Margin	0.12%	-4.18%	-3.51%	-5.88%	0.51%	4.57%	Upgrade
Free Cash Flow Margin	9.50%	8.40%	12.48%	0.74%	9.12%	15.92%	Upgrade
EBITDA	625.18	584.55	500.78	440.21	450	381.05	Upgrade
EBITDA Margin	21.91%	20.92%	20.92%	19.90%	21.49%	19.12%	Upgrade
D&A For EBITDA	245.36	236.19	229.4	240.18	233.41	235.39	Upgrade
EBIT	379.82	348.36	271.38	200.03	216.6	145.66	Upgrade
EBIT Margin	13.31%	12.47%	11.34%	9.04%	10.35%	7.31%	Upgrade
Effective Tax Rate	42.62%	-	-	-	35.70%	-	Upgrade
Advertising Expenses	-	34.4	12.4	16.8	-	-	Upgrade

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q